Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R, Staufer K, Traussnigg S, Stättermayer AF, Halilbasic E, Keritam O, Meyer EL, Stift J, Wrba F, Sipos B, Canbay A, Schlattjan M, Aigner E, Datz C, Stickel F, Schafmayer C, Hampe J, Buch S, Prager G, Munda P, Mandorfer M, Ferenci P, Trauner M.
Paternostro R, et al. Among authors: traussnigg s.
Hepatol Int. 2021 Aug;15(4):922-933. doi: 10.1007/s12072-021-10200-y. Epub 2021 Jun 2.
Hepatol Int. 2021.
PMID: 34076851
Free PMC article.